Clindamycin Oral Capsule 150Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Clindamycin: Oral capsule (150mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_2422.JPG
Clindamycin 150mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: 93 3171 93 3171,TEVA 3171 
Drug Image file DrugItem_729.JPG
Clindamycin 150mg Cap
Greenstone Ltd
Pill Identification: G 150mg 3328 
Drug Image file DrugItem_17417.JPG
Clindamycin 150mg Cap
Aurobindo Pharma USA Inc.
Pill Identification: C 39 
Drug Image file DrugItem_2142.JPG
Clindamycin 150mg Cap
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: DAN 5708 DAN 5708 
Drug Image file DrugItem_2827.JPG
Clindamycin 150mg Cap
Mylan Institutional LLC formerly UDL Laboratories Inc
Pill Identification: 93 3171 93 3171 

What is this Medicine?

CLINDAMYCIN (KLIN da MYE sin) is a lincosamide antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

CVS Pharmacy Patient Statistics for Clindamycin: Oral capsule(150mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Clindamycin Hydrochloride 150mg Capsule

NDC: 000933171
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Bacteremia, Pelvic Cellulitis, Peritonitis, Aspiration Pneumonia, Pneumonia, Empyema, Impetigo, Intraabdominal Infections, Bone And Joint Infections, Septicemia, Intraabdominal Abscess, Infectious Arthritis, Osteomyelitis, Pelvic Inflammatory Disease (PID), Gynecologic Infections, Cellulitis, Skin And Skin Structure Infections, Endometritis, Lower Respiratory Tract Infections, Tubo-ovarian Abscess, Lung Abscess

Sometimes used for but not FDA approved for the following conditions:
Pneumocystis Pneumonia (PCP), Endocarditis Prophylaxis, Dental Infection, Pharyngitis, Toxoplasmosis, Dental Abscess (apical), Dentoalveolar Infection, Toxoplasmic Encephalitis, Dental Abscess (periapical), Periodontitis, Rheumatic Fever Prophylaxis, Toxoplasmosis Prophylaxis, Malaria, Orthopedic Device-related Infection, Endodontic Infection, Bacterial Vaginosis

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Clindamycin Hydrochloride 150mg Capsule
Drug Image file DrugItem_2422.JPG
Teva Pharmaceuticals USA Inc
Pill Identification: 93 3171 93 3171,TEVA 3171 
Shape: capsule
Color: blue,red

Reported Side Effects for Clindamycin Hydrochloride 150mg Capsule

Infection Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Red, Pimple Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Drug Reaction With Eosinophilia And Systemic Symptoms (DRESS) Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yeast Infection Incidence:
<14.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<20.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<11.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Vaginal Infection Incidence:
<3.6%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Clindamycin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.